← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vasculox, Inc.
Saint Louis, MO
$3,507,559
Total funding
6
Grants
Funding over time
peak $1.6M · FY2009–14$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,507,559 · 6
By mechanism
R44$2,530,738 · 2
R41$497,398 · 2
R43$479,423 · 2
Investigators at Vasculox, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Treatment of Transplant Reperfusion with CD47 antibody$827,018
R44 · FY2013 · HL
Treatment of Transplant Reperfusion with CD47 antibody$706,733
R44 · FY2012 · HL
Anti-CD47 mAb Therapy to Improve Kidney Transplantation$499,799
R44 · FY2013 · DK
Anti-CD47 mAb Therapy to Improve Kidney Transplantation$497,188
R44 · FY2014 · DK
Tumor-toxic CD47 mAb therapy for leukemia: a proof of concept study$299,687
R41 · FY2013 · CA
Anti-CD47 mAb Therapy to Improve Kidney Transplantation$276,232
R43 · FY2011 · DK
Treatment of Transplant Reperfusion with an Anti-CD47 Antibody$203,191
R43 · FY2009 · HL
Development of a humanized anti-CD47 antibody for treatment of tissue ischemia.$197,711
R41 · FY2009 · HL